New immunotherapy cocktail aims to stall pancreatic cancer after chemo
NCT ID NCT07199764
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial tests a combination of two immunotherapy drugs, odetiglucan and mitazalimab, as a maintenance treatment for people with unresectable pancreatic cancer that has not worsened after 4-8 months of standard chemotherapy. The study will enroll 100 adults and measure how long the cancer stays under control. The goal is to see if this approach can delay disease progression and improve outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Odetiglucan and mitazalimab (two immunotherapy drugs given together intravenously every 3 weeks)
- What this could lead to
- If successful, this could offer a new maintenance treatment option to help keep pancreatic cancer from growing after initial chemotherapy.
- What could go wrong
- This is an early Phase 2 trial with only 100 participants and no comparison group, so results may not apply broadly. Immunotherapy can cause serious immune-related side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can High-Dose vitamin c boost Chemo's punch against pancreatic cancer?
- Four-Drug cocktail aims to shrink pancreatic tumors before surgery
- Exercise before and after pancreatic cancer surgery may speed recovery and chemotherapy start
- Could a simple blood test catch pancreatic cancer before It's too late?
- New drug combo aims to boost Chemotherapy's punch against pancreatic cancer
- New drug cocktail aims to shrink pancreatic tumors before surgery